The path from a few lead candidates to approval of First-In-Human (FIH) studies is long and complex. Selecting the right contract research organization (CRO) with a strong track record is important. The ideal CRO meets your scientific and operational needs. It speeds up your research and reduces risk. At Scantox, a global preclinical CRO, we believe that excellence lies in the detail. Not only in what we offer but also in how and how quickly we deliver.
Commitment to Speed & Personal Engagement
We make you a simple but important promise: We will turn your inquiries into actionable insights in 24 hours. If you have any questions about your study design or our capabilities, or need an in-depth discussion about toxicology or bioanalysis, you’ll get a response from a business development representative or client service team. Our global presence allows that we’re ready to assist you around the clock.
We also direct your questions to our subject matter experts through a quick triage process. This ensures you get immediate scientific support. Our scientists lead you through the next steps and help you to make informed decisions. This blend of speed and scientific understanding guarantees specific and comprehensive assistance throughout your project.
What specific expertise and problem-solving solutions do we offer to guide you through your project?
Ensuring Excellence in Scientific Support
At Scantox, our qualified scientists deliver comprehensive services with validated workflows, all embedded in a high-quality organization. We can support you at every stage of preclinical drug development. From lead candidate optimization and rigorous toxicity and safety testing to state-of-the-art bioanalytical testing and dose formulation.
Here are some examples to illustrate the breadth and depth of our capabilities:
- Discovery Division Expertise: Experienced scientists offer deep expertise and innovative assays in the field of the central nervous system (CNS).
- Bioanalytical Solutions: Our bioanalytical experts provide tailored problem-solving experience. From method development, transfer, and validation for analyzing small molecules with LC-MS/MS technology.
- Preclinical Models and IND-Enabling Solutions: A comprehensive suite of innovative animal disease models for efficacy testing, along with customized IND-enabling solutions. These options allow you to choose the most suitable support to meet the unique demands of your project.
This strategic business segmentation shows the commitment of our leadership to deliver seamless and integrated service solutions. From the inception of a drug to its final development.
Accelerating Outcomes Through Swift, Informed Engagement
Scantox’s key impact is turning fast and informed engagement into real benefits for our clients. Imagine a scenario where fast response and expert guidance shorten a project’s timeline. They enable a quicker transition from preclinical studies to FIH studies. By connecting these measurable outcomes to the initial challenges outlined at the beginning, we position Scantox as not just a service provider but as a strategic partner.
An Open Invitation
To ensure the success of your project, engage with us early. Don’t wait until the last moment. Allow time for meaningful discussions, research, and consultations with a dedicated project team. It’s also about building a relationship and decreasing the risks linked to inexperience.
We invite drug development companies who are looking for a high-quality and agile mid-sized CRO.
Contact us today and we will get back to you within 24 hours. Let’s discuss your challenges!
